Type 2 Diabetes Restricts Multipotency of Mesenchymal Stem Cells and Impairs Their Capacity to Augment Postischemic Neovascularization in <i>db/db</i> Mice
Journal of the American Heart Association. Cardiovascular and cerebrovascular disease